BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 79622)

  • 1. Epidermal cytoplasmic antigens: II. Concurrent presence of antigens of different specificities in normal human skin.
    Bystryn JC; Nash M; Robins P
    J Invest Dermatol; 1978 Aug; 71(2):110-3. PubMed ID: 79622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic differentiation antigens of human epidermal cells.
    Bystryn JC; Frances C
    Transplantation; 1979 Jun; 27(6):392-6. PubMed ID: 88782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in antigenic properties of normal epidermis adjacent to basal cell carcinomas.
    Wolf D; Bystryn JC
    J Invest Dermatol; 1981 Jun; 76(6):442-4. PubMed ID: 7240790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to basal epidermal cells in patients with basal or squamous cell carcinoma.
    Ackermann-Schopf CM
    Arch Dermatol Res (1975); 1976 Dec; 257(2):149-56. PubMed ID: 1008612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal cytoplasmic antibodies: incidence and type in normal persons and patients with melanoma.
    Abel EA; Bystryn JC
    J Invest Dermatol; 1976 Jan; 66(1):44-8. PubMed ID: 1107434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to human epidermal cytoplasmic antigens: incidence, patterns, and titers.
    Paluch EP; Bloch KJ
    J Invest Dermatol; 1982 Aug; 79(2):115-8. PubMed ID: 7047651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of a cross-reacting antigen common to multilaminar epithelia and group A streptococcus in cells of human epidermal tumors].
    Beletskaia LV; Berenbeĭn BA; Silagadze DG; Kolesnikova VIu; Ezhov NIa
    Biull Eksp Biol Med; 1981 Jun; 91(6):712-4. PubMed ID: 6168316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of epithelial antigens Exo-1 and EPM-1 in human epidermal keratinocyte maturation and benign and malignant neoplasia.
    Klingel R; Boukamp P; Moll R; Tilgen W; Fusenig NE; Meyer zum Büschenfelde KH; Dippold WG
    Cancer Res; 1990 Dec; 50(23):7668-76. PubMed ID: 2253212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal antibody labelling the keratinocyte membrane: a marker of epidermal differentiation.
    Viac J; Haftek M; Staquet MJ; Reano A; Brochier J; Thivolet J
    Acta Derm Venereol; 1985; 65(1):1-8. PubMed ID: 2578699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The localization of structurally specific antigens in squamous cell skin cancer using monoclonal antibodies to epidermal antigens].
    Kogan MG; Berenbeĭn BA; Drobyshevskaia EI; Abyzov VN; Spitsin SV
    Vopr Onkol; 1989; 35(9):1032-6. PubMed ID: 2479174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cross-reacting antigen common to stratified squamous epithelium and Streptococcus group A in tumors of epidermal origin].
    Silagadze DG; Beletskaia LV; Berenbein VA; Kolesnikova VIu
    Vopr Onkol; 1981; 27(6):27-32. PubMed ID: 7023039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental production of antibodies against stratum corneum keratin polypeptides.
    Viac J; Staquet MJ; Thivolet J; Goujon C
    Arch Dermatol Res; 1980; 267(2):179-88. PubMed ID: 6157367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial distribution of a myelomonocytic antigen LI in relation to cutaneous malignancies and melanocytic naevi.
    Gabrielsen TO; Brandtzaeg P; Hoel PS; Dale I
    Br J Dermatol; 1988 Jan; 118(1):59-67. PubMed ID: 3277660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of neu (c-erbB-2) protein in human skin.
    Maguire HC; Jaworsky C; Cohen JA; Hellman M; Weiner DB; Greene MI
    J Invest Dermatol; 1989 Jun; 92(6):786-90. PubMed ID: 2470827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal expression of G71 antibody at the epidermal basement membrane in basal cell carcinoma.
    Tidman MJ; Aplin JD; MacDonald DM
    Cancer; 1990 May; 65(9):1955-9. PubMed ID: 1695541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of Fas and FasL pro-apoptotic proteins in basal cell and squamous cell carcinomas.
    Wang XY; Zhang R; Lian S
    Clin Exp Dermatol; 2011 Jan; 36(1):69-76. PubMed ID: 20497185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas ligand is expressed in normal skin and in some cutaneous malignancies.
    Lee SH; Jang JJ; Lee JY; Kim SY; Park WS; Shin MS; Dong SM; Na EY; Kim KM; Kim CS; Kim SH; Yoo NJ
    Br J Dermatol; 1998 Aug; 139(2):186-91. PubMed ID: 9767230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-2-microglobulin and HLA-DR(Ia)-antigens in normal and pathological skin.
    Tjernlund U
    Acta Derm Venereol Suppl (Stockh); 1981; 94():1-40. PubMed ID: 6169248
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA and beta 2-microglobulin expression in basal and squamous cell carcinomas of the skin.
    Hua LA; Kagen CN; Carpenter RJ; Goltz RW
    Int J Dermatol; 1985 Dec; 24(10):660-3. PubMed ID: 3910595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immunity in patients with basal and squamous cell skin cancer.
    Weimar VM; Ceilley RI; Goeken JA
    J Am Acad Dermatol; 1980 Feb; 2(2):143-7. PubMed ID: 6965945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.